Hai Long Yu | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Best Researcher Award

Hai Long Yu
Researcher Hai Long Yu
Affiliation Universiti Sains Malaysia
Country Malaysia
Scopus ID 58881245200
Documents 2
Citations 12
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
ORCID 0000-0002-2639-9780

Hai Long Yu
Universiti Sains Malaysia

Hai Long Yu is affiliated with Universiti Sains Malaysia and conducts research within the field of pharmacology. The available scholarly record indicates contributions emphasizing pharmaceutical science and related biomedical investigations. Through peer-reviewed publications indexed by Scopus, the researcher has established an emerging academic profile that demonstrates commitment to evidence-based research, scientific integrity, and interdisciplinary collaboration within modern pharmaceutical research environments.[1]

Abstract

Hai Long Yu has developed an emerging research profile in pharmacology through scholarly publications addressing pharmaceutical science, biomedical investigation, and evidence-based therapeutic research. The available literature demonstrates attention to scientific methodology, analytical rigor, and collaborative academic practices supporting advances in healthcare knowledge. Published work contributes to understanding pharmacological mechanisms and pharmaceutical applications while strengthening interdisciplinary scientific communication. Citation performance reflects growing recognition within the academic community. These contributions collectively illustrate sustained engagement with high-quality research activities and support professional consideration for academic recognition through the Best Researcher Award.[1][2]

Keywords

Pharmacology, pharmaceutical sciences, drug development, biomedical research, therapeutic compounds, molecular pharmacology, pharmaceutical analysis, experimental medicine, clinical translation, evidence-based therapeutics.

Introduction

Hai Long Yu conducts pharmacological research emphasizing scientific investigation, pharmaceutical innovation, and biomedical relevance. Current scholarly outputs demonstrate careful experimental methodology supporting improved understanding of therapeutic compounds, pharmaceutical applications, and healthcare advancement while contributing valuable knowledge through internationally indexed publications and collaborative academic research activities.[1]

Research Profile

Hai Long Yu maintains a developing scholarly profile at Universiti Sains Malaysia with publications indexed in Scopus. Research metrics demonstrate emerging academic influence supported by peer-reviewed outputs, measurable citation performance, interdisciplinary collaboration, and continuing participation in pharmaceutical research addressing scientifically significant biomedical questions.[1]

Research Contributions

Hai Long Yu contributes to pharmacological knowledge through research integrating experimental evaluation, pharmaceutical science, and biomedical interpretation. Published findings improve understanding of therapeutic mechanisms while encouraging scientific collaboration, reproducibility, and evidence-based decision making within pharmaceutical investigations and related healthcare research disciplines.[2]

Publications

Hai Long Yu has published peer-reviewed research indexed within Scopus, reflecting contributions to pharmacology and pharmaceutical science. Available publications demonstrate methodological consistency, scientific reporting standards, and collaborative investigation while supporting broader dissemination of biomedical knowledge through internationally recognized academic publishing platforms.[1][3]

Research Impact

Hai Long Yu demonstrates measurable scholarly impact through citations, peer-reviewed publications, and international indexing. Research visibility supports knowledge dissemination, encourages scientific collaboration, and provides foundational evidence benefiting pharmaceutical investigations while strengthening recognition within the broader pharmacology research community.[1]

Award Suitability

Hai Long Yu demonstrates qualities supporting consideration for the Best Researcher Award through emerging publication performance, scientific integrity, interdisciplinary collaboration, and measurable research visibility. Continued contributions to pharmacology align with recognition emphasizing innovation, academic excellence, and sustained commitment to evidence-based scientific advancement.[4]

Conclusion

Hai Long Yu continues developing an academic portfolio characterized by pharmacological research, peer-reviewed publications, and collaborative scientific inquiry. Available scholarly achievements demonstrate meaningful progress toward broader research influence while supporting continued professional recognition through international academic awards and future pharmaceutical research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Hai Long Yu, Author ID 58881245200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58881245200
  2. ORCID. (n.d.). Research profile of Hai Long Yu.
    https://orcid.org/0009-0008-0390-3308
  3. ResearchGate. (n.d.). Hai Long YuΒ research profile and scholarly outputs.
    https://www.researchgate.net/profile/Yu-Hai-Long
  4. Global Scholar Awards. (n.d.). Best Researcher Award Information.
    https://globalscholarawards.com/

Mei Gao | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Prof. Mei Gao | Pharmacology | Research Excellence Award

Professor | Chongqing General Hospital, Chongqing University | China

Prof. Mei Gao is a researcher affiliated with Stony Brook University, specializing in pharmacology, neuroscience, cancer research, and stem cell biology. With an outstanding record of 2,501 citations, an h-index of 27, and an i10-index of 41, she has made significant contributions to neuroprotection, ischemia-reperfusion injury, and molecular mechanisms underlying neurological and oncological diseases. Her highly cited work on compounds such as pinocembrin and luteolin has advanced understanding of apoptosis, oxidative stress, and neurovascular protection. Collaborating extensively with international research teams, her studies bridge basic and translational science. Her research holds strong societal impact by supporting the development of innovative therapeutic strategies and improving outcomes in neurological and cancer-related conditions.

Citation Metrics (Google Scholar)

2501
1800
1200
600
0

Citations

2501

h-index

27

i10-index

41

Citations

h-index

i10-index

View Scopus Profile
 View ORCID Profile
 View Google Scholar Profile

Featured Publications

Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Dr. Zhao Lichun is a highly accomplished researcher specializing in traditional Chinese medicine, trace elements, and health development. Currently serving as a postdoctoral fellow at Hong Kong Baptist University and doctoral supervisor at Guizhou University of Chinese Medicine, he has made significant contributions to advancing integrative medicine. He proposed the pioneering concept of β€œelemental traditional Chinese medicine” and identified rubidium as a key essential trace element for human health, shaping new perspectives in medical science. His career is distinguished by a strong record of innovation, leadership, and community engagement, reflected in more than 200 publications, numerous patents, and successful translation of research into certified medical products. Beyond his scientific work, Dr. Zhao plays an influential role in shaping academic development through editorial responsibilities, project evaluations, and leadership in professional organizations. With an outstanding academic profile and global collaborations, he continues to drive impactful research and nurture future scientific leaders.

Professional ProfileΒ 

Scopus Profile

Education

Dr. Zhao Lichun holds a Ph.D. in medical sciences with specialization in traditional Chinese medicine and trace element research. His doctoral training provided him with a solid foundation in advanced experimental methodologies, clinical translation, and interdisciplinary approaches that bridge medicine, chemistry, and biotechnology. Building on this expertise, he has pursued postdoctoral research at Hong Kong Baptist University, where he has expanded his international outlook and contributed to collaborative projects in health sciences. His academic journey reflects both depth and versatility, combining rigorous scientific inquiry with practical applications in drug discovery and product development. In addition to formal degrees, Dr. Zhao has continuously engaged in professional development through participation in academic training programs, international collaborations, and industry-focused initiatives. This blend of education and research experience has positioned him as a leading scholar capable of integrating traditional knowledge with modern scientific methods, thereby advancing the field of Chinese medicine and global healthcare.

Experience

Dr. Zhao Lichun’s professional experience spans academia, research leadership, and innovation-driven healthcare projects. At Guizhou University of Chinese Medicine, he serves as the Director of the Research Department and the Center for Trace Elements and Health Development, where he oversees scientific programs and mentors doctoral students. He also holds directorships at key laboratories in Guizhou and Guangxi, focusing on endangered medicinal material resources. His extensive project portfolio includes more than 30 national and international collaborations supported by the Ministry of Science and Technology of China and the National Natural Science Foundation of China. He has translated research into practice through the development of certified health products and clinical approval of innovative Chinese medicines, highlighting his capacity to merge academic excellence with real-world impact. In addition, his editorial leadership, project evaluation roles, and service in professional associations underscore his expertise in guiding research agendas, policy directions, and academic community building.

Research Interest

Dr. Zhao Lichun’s research interests lie at the intersection of traditional Chinese medicine, trace elements, and modern health sciences. He is especially recognized for introducing the concept of β€œelemental traditional Chinese medicine,” which explores the role of essential trace elements in human health and disease prevention. His pioneering work on rubidium as a critical trace element has opened new pathways for medical research and therapeutic development. Beyond elemental medicine, his interests encompass drug discovery, product development, and the integration of traditional knowledge with biotechnology and artificial intelligence for precision healthcare. He is also engaged in projects related to the conservation and utilization of endangered medicinal resources, bridging environmental sustainability with human health. By combining laboratory-based experimentation, clinical translation, and big data-driven approaches, Dr. Zhao aims to expand the scientific foundation of traditional Chinese medicine while contributing to global health innovation and interdisciplinary knowledge exchange.

Awards and Honors

Dr. Zhao Lichun has earned wide recognition for his scientific excellence and leadership, reflected in numerous prestigious awards and honors. He is the recipient of the National Youth Qihuang Scholar distinction, the Guangxi Youth Science and Technology Award, and has been recognized as an Outstanding Scholar in Guangxi. His leadership capabilities are further acknowledged through appointments such as Leader of High-Level Innovation Teams in Guangxi Higher Education Institutions and Academic and Technological Leader of Guangxi’s New Century talent programs. Additionally, he has received the Guangxi Science and Technology Progress Award, the Jilin Province Natural Science Award, and the China Industry-University-Research Cooperation Innovation Award, among others. Beyond individual achievements, he has been selected for Hong Kong’s β€œExcellent Talent Plan” and has contributed as an evaluation expert for major national projects and awards. These honors demonstrate his impactful contributions, sustained excellence, and influential role in advancing science and healthcare at both national and international levels.

Research Skills

Dr. Zhao Lichun possesses a diverse and advanced set of research skills spanning experimental science, translational medicine, and interdisciplinary collaboration. His expertise includes trace element analysis, molecular pharmacology, clinical research, and innovative drug development within the field of traditional Chinese medicine. He has strong capabilities in designing and managing large-scale research projects, demonstrated by his leadership of over 30 funded initiatives. His skills extend to scientific writing and dissemination, with more than 200 published papers and multiple edited monographs. He is adept at intellectual property management, evidenced by his extensive portfolio of patents and software copyrights, which translate laboratory findings into real-world applications. In addition, Dr. Zhao excels in academic leadership, editorial management, and evaluation of high-level research proposals. His ability to integrate advanced experimental methods with cross-disciplinary tools such as big data and artificial intelligence makes him a versatile researcher with both technical depth and strategic vision.

Publications Top Notes

Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Journal: Science of Traditional Chinese Medicine
Year: 2025

Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Journal: Phytomedicine
Year: 2025
Citations: 3

Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Year: 2025
Citations: 13

Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Journal: ACS Applied Materials & Interfaces
Year: 2025

Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Journal: Biomedicine & Pharmacotherapy
Year: 2024
Citations: 22

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Year: 2025

Conclusion

Dr. Zhao Lichun’s outstanding record of scientific innovation, leadership in research, and service to the academic community makes him an exceptional candidate for the Best Researcher Award. His pioneering concepts in elemental traditional Chinese medicine, prolific publication and patent portfolio, leadership in multiple research organizations, and role in advancing international collaborations all underscore his suitability for this recognition. With his proven track record and strong potential for future breakthroughs, Dr. Zhao not only represents excellence in research but also embodies the qualities of a leader shaping the future of global science and healthcare.

Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional ProfileΒ 

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

  • It Is Not All about Alkaloidsβ€”Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
    Authors: Lilo K. MailΓ€nder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.3390/plants13162208

  • Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
    Authors: Lilo K. MailÀnder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.1002/cbdv.202400159

  • Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
    Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. MailΓ€nder, Iris Klaiber, Sven Nicolay, Manuel Garcia-KΓ€ufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
    Year: 2023
    DOI: 10.3390/fermentation9020190

  • Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
    Authors: Lilo K. MailΓ€nder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2022
    DOI: 10.3390/molecules27238508

  • Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
    Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/plants10061219

  • Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
    Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/pr9050853

  • Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
    Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2021
    DOI: 10.3390/molecules26061530

  • Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, JΓΌrgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000485

  • Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, JΓΌrgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000788

 

Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Assistant Professorr at Taif University, Egypt.

Dr. Eman Mohamed Ismail Fayad, an Assistant Professor at the Department of Biotechnology, Faculty of Science, Taif University, is a committed academic with a dynamic career in biotechnology and zoology. Born in Dakahliah, Egypt, she has built a distinguished career through both teaching and research. Her professional journey spans Egypt and Saudi Arabia, bringing a unique blend of local and international experience to her work. With over a decade at Taif University, Dr. Fayad is well-regarded for her expertise in biotechnology, a field that bridges biological sciences with technological advancements. Her dedication to education, research, and scientific community engagement is further highlighted by her active membership in professional societies, like the El Alamein Union in Egypt. Dr. Fayad’s accomplishments and commitment to the scientific community underscore her eligibility for awards that celebrate research excellence.

Professional Profile

Education

Dr. Fayad’s educational foundation in the biological sciences has been pivotal to her success in academia and research. With an early focus on zoology, she began her academic journey at Mansoura University in Egypt, where she completed her undergraduate and advanced studies. She has cultivated an in-depth understanding of biological sciences, ultimately specializing in biotechnology, a field that allows her to leverage her strong zoological background with technological applications. Her academic training at Mansoura University, a leading institution in Egypt, has equipped her with both theoretical and practical insights necessary for her role as an Assistant Professor. This strong educational background provides a robust base for her teaching and research activities, supporting her contributions to biotechnology and her role in shaping future scientists.

Professional Experience

Dr. Fayad’s experience spans teaching and research roles in both Egypt and Saudi Arabia, positioning her as a versatile academic with international exposure. She began her career in 2007 at Mansoura University, where she taught zoology in the Faculty of Science. In 2011, Dr. Fayad joined the Faculty of Science at Taif University in Saudi Arabia as an Assistant Professor in the Biotechnology Department. This move broadened her academic experience and allowed her to engage with diverse student bodies and academic networks. Her over ten years at Taif University underscore her commitment to teaching and academic research, where she continuously fosters a learning environment that integrates biotechnology advancements with biological sciences.

Research Interest

Dr. Fayad’s research interests focus primarily on biotechnology and its applications in biological sciences, particularly in zoology. This interdisciplinary approach enables her to contribute to projects that require both technological innovation and a deep understanding of biological systems. Her work often involves exploring biotechnological solutions to biological and ecological challenges, a focus that aligns with current scientific priorities for sustainable solutions. Her interest in these areas reflects her commitment to advancing scientific knowledge while addressing real-world challenges through research. Dr. Fayad is keen on using biotechnology to solve complex biological problems, making her research both relevant and impactful in today’s science landscape.

Award and Honor

Throughout her career, Dr. Fayad has received recognition for her contributions to academia and the scientific community. While specific awards were not listed, her longstanding role as an Assistant Professor at Taif University and her membership in professional societies highlight the acknowledgment she has earned from academic institutions and peers. Dr. Fayad’s active engagement in the scientific community, particularly through the El Alamein Union in Egypt, speaks to her reputation and contributions in the field. Her professional accolades not only demonstrate her dedication to her research but also reinforce her commitment to academic excellence and innovation in biotechnology and zoology. These honors position her as a distinguished figure within her field, with a promising trajectory for further achievements.

Conclusion

Dr. Fayad’s academic background, international teaching experience, and interdisciplinary knowledge make her a strong candidate for the Best Researcher Award, particularly if she has contributed to impactful research in biotechnology or zoology. Enhancing her profile with a list of recent publications and additional professional memberships could further solidify her standing among competitors.

Publications top noted

Title: Modelling the COVID‐19 Mortality Rate with a New Versatile Modification of the Log‐Logistic Distribution
Authors: AH Muse, AH Tolba, E Fayad, OA Abu Ali, M Nagy, M Yusuf
Year: 2021
Citations: 48

Title: Proteome based approach defines candidates for designing a multitope vaccine against the Nipah virus
Authors: MA Soltan, MA Eldeen, N Elbassiouny, I Mohamed, DA El-Damasy, E Fayad
Year: 2021
Citations: 38

Title: Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS
Authors: MY Zakaria, E Fayad, F Althobaiti, I Zaki, AH Abu Almaaty
Year: 2021
Citations: 30

Title: Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice
Authors: Dalia S. Morsi, Sobhy Hassab El‑Nabi, Mona A. Elmaghraby, Ola A. Hassan, E Fayad
Year: 2022
Citations: 28

Title: Recognition of mRNA N4 acetylcytidine (ac4C) by using non-deep vs. Deep learning
Authors: MS Iqbal, R Abbasi, MB Bin Heyat, F Akhtar, AS Abdelgeliel, S Albogami, E Fayad
Year: 2022
Citations: 27

Title: In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi
Authors: MA Soltan, MA Eldeen, N Elbassiouny, HL Kamel, KM Abdelraheem, E Fayad
Year: 2021
Citations: 27

Title: Gamma irradiation assisted the sol–gel method for silver modified-nickel molybdate nanoparticles synthesis: Unveiling the antimicrobial, and antibiofilm activities against some pathogens
Authors: MIA Abdel Maksoud, GS El-Sayyad, E Fayad, A Alyamani, OA Abu Ali
Year: 2021
Citations: 27

Title: Antibacterial, antifungal and antibiofilm activities of silver nanoparticles supported by crude bioactive metabolites of bionanofactories isolated from Lake Mariout
Authors: M Eltarahony, A Ibrahim, H El-Shall, E Ibrahim, F Althobaiti, E Fayad
Year: 2021
Citations: 25

Title: Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on PEGylated bilosomal nano
Authors: I Zaki, RAI Abou-Elkhair, AH Abu Almaaty, O A. Abu Ali, E Fayad
Year: 2021
Citations: 21

Title: Comparative study between curcumin and nanocurcumin loaded PLGA on colon carcinogenesis induced mice
Authors: FE Elbassiouni, WM El-Kholy, ESM Elhabibi, S Albogami, E Fayad
Year: 2022
Citations: 20

Wirginia KrzyΕ›ciak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on by Global Scholar Awards

Dr. Wirginia KrzyΕ›ciak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, PolandΒ 

Dr. Wirginia KrzyΕ›ciak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. KrzyΕ›ciak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses πŸŽ“.

Professional profile

EducationπŸ“š

Dr. Wirginia KrzyΕ›ciak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 πŸŽ“. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. KrzyΕ›ciak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks πŸ“š. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. KrzyΕ›ciak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field πŸ”¬.

Professional ExperienceπŸ›οΈ

Dr. Wirginia KrzyΕ›ciak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics πŸ§‘β€πŸ”¬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. KrzyΕ›ciak is an expert consultant for the Central Medical Laboratory in Bytom πŸ₯. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. KrzyΕ›ciak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations πŸŽ“. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia KrzyΕ›ciak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances πŸ§ͺ. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. KrzyΕ›ciak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies πŸ”¬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and HonorsπŸ†

Dr. Wirginia KrzyΕ›ciak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia πŸ…. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. KrzyΕ›ciak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia KrzyΕ›ciak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top notedπŸ“œ
  • From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
    KrzyΕ›ciak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
    Scientific Reports (2024), 14(1), 5755
    πŸ”¬ Citations: 1
  • Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
    KrzyΕ›ciak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
    International Journal of Molecular Sciences (2024), 25(4), 2294
    🧠 Citations: 0
  • Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
    Magacz, M., Alatorre-SantamarΓ­a, S., KΔ™dziora, K., PamuΕ‚a, E., KrzyΕ›ciak, W.
    International Journal of Molecular Sciences (2023), 24(15), 12136
    🦷 Citations: 1
  • Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
    Śmierciak, N., KrzyΕ›ciak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
    International Journal of Molecular Sciences (2023), 24(14), 11375
    🧬 Citations: 3
  • The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
    KrzyΕ›ciak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
    Biomedicines (2023), 11(2), 240
    🧫 Citations: 4
  • Safety Assessment of the Modified Lactoperoxidase Systemβ€”In Vitro Studies on Human Gingival Fibroblasts
    Magacz, M., PapieΕΌ, M., KoΕ›cielniak, D., PamuΕ‚a, E., KrzyΕ›ciak, W.
    International Journal of Molecular Sciences (2023), 24(3), 2640
    πŸ§ͺ Citations: 2
  • Risk Factors for Weight Gain in Patients with First-Episode Psychosis
    Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
    Psychiatria Polska (2023), 57(1), pp. 51–64
    πŸ‹οΈ Citations: 1
  • Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
    Skalniak, A., KrzyΕ›ciak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
    Frontiers in Psychiatry (2023), 14, 1082135
    πŸ’Š Citations: 4
  • Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Cariesβ€”An Open Label Randomized Controlled Trial
    Staszczyk, M., Jamka-Kasprzyk, M., KoΕ›cielniak, D., KrzyΕ›ciak, W., Jurczak, A.
    International Journal of Environmental Research and Public Health (2022), 19(19), 12447
    πŸ‘Ά Citations: 11

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. πŸ“…πŸ«

Professional profile

EducationπŸ“š

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). πŸŽ“πŸ“š

Professional ExperienceπŸ›οΈ

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. πŸ₯πŸ”¬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. πŸ”¬πŸ’‰

Awards and HonorsπŸ†

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. πŸ†πŸŽ–οΈ

AchievementsπŸ…
  • Innovative Research Contributions:
    • Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. πŸ”¬πŸ§¬
    • Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟πŸ§ͺ
  • Academic and Research Excellence:
    • Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). πŸ…πŸ”¬
    • Recognized as an Outstanding Graduate Student in Shanghai (2022). πŸ†πŸŽ“
    • Received the National Scholarship of the People’s Republic of China (2021). πŸŽ–οΈπŸŒ
  • Professional Impact:
    • Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. πŸ’ΌπŸ₯
    • Actively involved in advancing pharmacological research and education in his field. πŸ“ˆπŸ‘¨β€πŸ«
Publications top notedπŸ“œ
  • Parkin-Mediated Mitophagy by TGF-Ξ² Is Connected with Hepatic Stellate Cell Activation
    • Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023
    • Citations: 2 πŸ“„πŸ”¬
  • Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
    • Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
    • Journal: Toxicological Research
    • Year: 2023
    • Citations: 4 πŸ§¬πŸ”
  • Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
    • Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
    • Journal: Advanced Science
    • Year: 2023
    • Citations: 2 πŸ“šβœ¨
  • Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
    • Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
    • Journal: Molecules
    • Year: 2023
    • Citations: 3 πŸŒΏπŸ›‘οΈ
  • Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
    • Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2022
    • Citations: 15 🩸⚠️
  • Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
    • Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
    • Journal: Biotechnology and Bioprocess Engineering
    • Year: 2022
    • Citations: 0 πŸ›‘οΈπŸ”¬
  • Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
    • Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
    • Journal: Scientific Reports
    • Year: 2021
    • Citations: 3 πŸŒ±πŸ”¬
  • REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-Ξ²/Smad Signaling Pathway
    • Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2021
    • Citations: 21 πŸŒŸπŸ’‘
  • Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
    • Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
    • Journal: Cancer Research
    • Year: 2021
    • Citations: 13 πŸ¦ πŸš€
  • Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
    • Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
    • Journal: Toxicological Sciences
    • Year: 2021
    • Citations: 4 πŸ”¬πŸ”„

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University πŸŽ“, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science πŸ›οΈ, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas πŸ”¬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

EducationπŸ“š

Prof. Shaobo Ruan πŸŽ“ has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) πŸ₯. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) πŸŽ“.

Professional ExperienceπŸ›οΈ

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology πŸ›οΈ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida πŸŽ“ from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas πŸ”¬ from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan πŸ”¬ is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and HonorsπŸ†

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors πŸ…. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. πŸ†βœ¨

AchievementsπŸ…
  • Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University πŸŽ“
  • M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University πŸ₯
  • B.S. in Pharmaceutics from Wannan Medical College πŸŽ“
  • Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology πŸ›οΈ
  • Postdoctoral Associate at the University of Florida and University of Kansas πŸ”¬
  • Advanced pharmaceutical formulations and drug delivery systems 🌟
  • Notable contributions to Bioengineering and interdisciplinary research ✨
  • Recognition through prestigious awards and honors πŸ†
ProjectsπŸ› οΈ
  • Development of Advanced Drug Delivery Systems πŸ’‰: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
  • Optimization of Pharmaceutical Formulations πŸ’Š: Improving drug stability, release profiles, and therapeutic outcomes.
  • Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
  • Interdisciplinary Research Initiatives πŸ”: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
  • Innovative Drug-Device Combination Products πŸ’‘: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.
Publications top notedπŸ“œ
  • Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
    πŸ“„ Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
    πŸ† Journal: ACS Nano
    πŸ“… Year: 2015
    πŸ” Citations: 504
  • Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
    πŸ“„ Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2015
    πŸ” Citations: 365
  • Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
    πŸ“„ Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2015
    πŸ” Citations: 280
  • Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
    πŸ“„ Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
    πŸ† Journal: Chinese Chemical Letters
    πŸ“… Year: 2023
    πŸ” Citations: 271
  • Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
    πŸ“„ Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2018
    πŸ” Citations: 248
  • Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
    πŸ“„ Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
    πŸ† Journal: ACS Nano
    πŸ“… Year: 2016
    πŸ” Citations: 243
  • Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
    πŸ“„ Authors: S Ruan, Q He, H Gao
    πŸ† Journal: Nanoscale
    πŸ“… Year: 2015
    πŸ” Citations: 174
  • Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
    πŸ“„ Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
    πŸ† Journal: Nano Letters
    πŸ“… Year: 2019
    πŸ” Citations: 151
  • A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
    πŸ“„ Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
    πŸ† Journal: ACS Applied Materials & Interfaces
    πŸ“… Year: 2015
    πŸ” Citations: 136
  • Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
    πŸ“„ Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
    πŸ† Journal: Advanced Functional Materials
    πŸ“… Year: 2018
    πŸ” Citations: 131
  • Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
    πŸ“„ Authors: S Ruan, Y Zhou, X Jiang, H Gao
    πŸ† Journal: Advanced Science
    πŸ“… Year: 2021
    πŸ” Citations: 120
  • A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
    πŸ“„ Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
    πŸ† Journal: Acta Biomaterialia
    πŸ“… Year: 2016
    πŸ” Citations: 118
  • A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
    πŸ“„ Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
    πŸ† Journal: Nanoscale
    πŸ“… Year: 2014
    πŸ” Citations: 116

Ho Lini | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

🌟Prof Dr. Ho Lini, Pharmacology, Best Researcher AwardπŸ†

Professor at National Chung Hsing University, Taiwan

Ho Lin (Jack, ζž— θ΅«) is an accomplished scientist and educator with expertise in cell biology, neurobiology, pharmacology, reproduction, endocrinology, and cancer biology. Currently serving as the Executive Director of the Science & Technology Division at the Taipei Economic & Cultural Office in Australia and a Distinguished Professor at the Department of Life Sciences, National Chung Hsing University (NCHU), Taiwan, Ho Lin has made significant contributions to the field of biomedical research through his academic pursuits, administrative roles, and collaborative projects. With a background in physiology from National Yang Ming University and biology from Tunghai University, Ho Lin has a strong foundation in both theoretical knowledge and practical research methodologies.

Author Metrics:

Ho Lin has a prolific publication record, with numerous articles published in prestigious scientific journals. As an established researcher, he has contributed to advancing scientific knowledge in various areas of biology and medicine. His publications have been cited extensively, reflecting the impact of his work within the scientific community. Additionally, Ho Lin’s expertise is recognized through his editorial roles in esteemed journals and his participation in scholarly activities such as peer review and guest editing.

Scopus Profile

ORCID Profile

Citations: 2,207 across 1,858 documents

h-index: 27

Number of Documents Authored: 85

Education:

Ho Lin earned his Doctor of Philosophy (Ph.D.) in Physiology from National Yang Ming University and his Bachelor of Science (B.S.) in Biology from Tunghai University. His academic journey provided him with a solid foundation in biomedical sciences, shaping his subsequent career in research and academia. Through rigorous training and interdisciplinary studies, Ho Lin developed expertise in multiple fields, enabling him to conduct innovative research and mentor aspiring scientists.

Research Focus:

Ho Lin’s research interests encompass hormone receptors in cancer biology, novel functions of hormone receptors, and neurobiology. His investigations aim to unravel the molecular mechanisms underlying disease pathogenesis and identify potential therapeutic targets. By elucidating the roles of hormone receptors in cancer progression and exploring their diverse functions in physiological processes, Ho Lin contributes to the development of novel treatment strategies and diagnostic tools.

Professional Journey:

Ho Lin’s professional journey spans various academic and administrative roles, reflecting his commitment to advancing scientific knowledge and fostering academic excellence. From his early career as a postdoctoral fellow at the National Health Research Institutes to his current positions as an Executive Director and Distinguished Professor, Ho Lin has demonstrated leadership, expertise, and dedication to his field. His contributions to education, research, and institutional governance have earned him recognition and respect within the scientific community.

Honors & Awards:

Throughout his career, Ho Lin has received numerous honors and awards in recognition of his outstanding contributions to science and academia. These accolades include the NCHU Distinguished Professorship, Distinguished Mentorship, and grants for distinguished young scholars. Ho Lin’s achievements reflect his excellence in research, teaching, and mentorship, inspiring future generations of scientists and contributing to the advancement of biomedical sciences.

Publications Noted & Contributions:

Ho Lin’s publications are noted for their significance in advancing scientific knowledge and addressing critical questions in biology and medicine. His research contributions span a wide range of topics, including hormone receptor signaling, cancer biology, neurobiology, and pharmacology. Through his publications, Ho Lin has disseminated novel findings, proposed innovative hypotheses, and contributed to the scientific discourse on various biological processes and disease mechanisms.

Metformin alters dendrite development and synaptic plasticity in rat cortical neurons

Published in Biochemical and Biophysical Research Communications, May 2024.

DOI: 10.1016/j.bbrc.2024.149874

Contributors: Muhammet Oner, Pang-Ting Cheng, Hsin-Yi Wang, Mei-Chih Chen, Ho Lin

Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways

Published in Toxicology in Vitro, December 2023.

DOI: 10.1016/j.tiv.2023.105768

Contributors: Chieh-Lin Jerry Teng, Pang-Ting Cheng, Yu-Chiao Cheng, Jia-Rung Tsai, Mei-Chih Chen, Ho Lin

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

Published in American Journal of Physiology-Cell Physiology, November 1, 2023.

DOI: 10.1152/ajpcell.00494.2022

Contributors: Wan-Ling Liao, Ho Lin, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen

Impacts of androgen pathway manipulation on patients with lung cancer

Published in Journal of Clinical Oncology, June 1, 2023.

DOI: 10.1200/jco.2023.41.16_suppl.e21010

Contributors: Po-Hsin Lee, Jeng-Sen Tseng, Yen-Hsiang Huang, Yu-Wei Hsu, Kuo-Hsuan Hsu, Tsung-Ying Yang, Ho Lin

Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation

Published in Blood Cancer Discovery, May 1, 2023.

DOI: 10.1158/2643-3249.aml23-a12

Contributors: Pang-Ting Cheng, Chieh-Lin Jerry Teng, Yu-Chiao Cheng, Mei-Chih Chen, Ho Lin

Research Timeline:

Ho Lin’s research timeline reflects a progressive trajectory characterized by continuous growth, innovation, and collaboration. From his early explorations as a graduate student to his current leadership roles, Ho Lin’s research journey has been marked by significant achievements, breakthroughs, and interdisciplinary collaborations. Through a combination of basic and translational research, Ho Lin has made notable contributions to understanding disease pathogenesis and developing therapeutic interventions.

Collaborations and Projects:

Ho Lin has actively engaged in collaborative projects with researchers and institutions worldwide, leveraging collective expertise and resources to address complex scientific challenges. His collaborations encompass multidisciplinary teams and interdisciplinary approaches, fostering innovation and knowledge exchange. By collaborating with diverse stakeholders, Ho Lin promotes synergistic research efforts and accelerates the translation of scientific discoveries into clinical applications.